ELOX Earnings — Eloxx Pharmaceuticals, Inc. Common Stock Post-ER Performance | BigEarnings
ELOX — Eloxx Pharmaceuticals, Inc. Common Stock
XNAS
Price$13.74
Market Cap$55.5M
P/E—
52W Range$0.00 – $23.40
Next Earnings2026-11-11
About Eloxx Pharmaceuticals, Inc. Common Stock
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
